Business ❯Finance ❯Investments ❯Stock Performance

Market Reactions

FDA Rejects Aldeyra's Reproxalap NDA for Dry Eye Disease Over Efficacy Issues

Fidelity National Shares Drop 16% Following Revenue Miss and Weak 2025 Forecast

Super Micro Appoints New Auditor to Avert Nasdaq Delisting

Super Micro Computer Faces Nasdaq Delisting Deadline

Palantir, Dell, and Erie Indemnity Join S&P 500 in Latest Rebalance